Dermatology Excimer Laser Market Size & Growth Forecast 2026–2035, By Segments (Product, End-use, Application), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growoth Outlook
Dermatology Excimer Laser Market size was valued at USD 690.29 Million in 2025 and is anticipated to grow at a 10.2% CAGR from 2026 to 2035, surpassing USD 1.82 Billion by 2035. The industry revenue for 2026 is calculated at USD 753.05 million.
Get more details on this report
Request Free Sample ReportDermatology Excimer Laser Market Intelligence Snapshot
Regional Market Dynamics
- North America held a 40.49% market share in 2025, supported by established dermatology infrastructure, specialist clinics, and consistent use of excimer laser treatments for chronic skin conditions.
- Asia Pacific is forecast to grow at an 11.42% CAGR as expanding dermatology services, greater laser device availability, and rising patient awareness increase adoption across hospitals and specialty clinics.
Segment Momentum
- Dermatology clinics led the market in 2025 because they remain the primary setting for diagnosing and routinely treating skin conditions requiring excimer laser therapy, supported by specialist expertise and consistent patient volumes.
- Hand-held excimer lasers are growing rapidly because they offer greater portability, flexible deployment, and suitability for smaller practices, supporting expanding outpatient treatment and more space-efficient clinical workflows.
Market Expansion Drivers
- Rising prevalence of psoriasis and vitiligo driving demand for targeted laser dermatology treatments.
- Growing preference for non-invasive cosmetic and dermatology procedures accelerating laser adoption.
- Integration of AI-enabled treatment planning improving precision and personalized dermatology care.
Leading Market Participants
Global Market Forecast Snapshot
Market Outlook
Top players in the dermatology excimer laser market include Ra Medical Systems, Inc. (United States), Lumenis Ltd. (Israel), Hologic, Inc. (United States), Fotona d.o.o. (Slovenia), Alma Lasers (Israel), Strata Skin Sciences, Inc. (United States), DEKA Research & Development Corp. (Italy), Beijing Sincoheren S&T Development Co., Ltd (China), Shenzhen GSD Tech Co., Ltd. (China), The Daavlin Company (United States).Regional and Segment Outlook
North AmericaMarket Growth Drivers and Industry Trends
A larger diagnosed patient pool for chronic pigmentary and inflammatory skin disorders is pushing providers to expand access to focused light-based therapies that can treat localized lesions without exposing unaffected skin. In the dermatology excimer laser market, this dynamic is especially important because psoriasis and vitiligo often require repeated management over time, making treatment precision, tolerability, and suitability for difficult-to-treat areas central to physician decision-making. As dermatologists look for options that fit between topical therapy and broader systemic intervention, excimer platforms gain traction by aligning with routine clinical care pathways for persistent, visible conditions that directly affect patient adherence and treatment-seeking behavior.
Growing preference for non-invasive cosmetic and dermatology procedures accelerating laser adoption
Patient behavior is shifting toward treatments that offer visible results with limited downtime, lower procedural burden, and fewer barriers than surgical or more aggressive therapeutic options. That preference is supporting market expansion in the dermatology excimer laser market by increasing acceptance of office-based laser procedures among both medical dermatology and cosmetic-oriented patient segments. Clinics and dermatology centers respond by investing in laser systems that can broaden service offerings while fitting high-throughput outpatient workflows, which in practice raises equipment utilization and strengthens the role of excimer devices in treatment portfolios built around minimally disruptive care.
Integration of AI-enabled treatment planning improving precision and personalized dermatology care
AI-enabled planning tools are making excimer laser use more data-guided by helping clinicians assess lesion characteristics, standardize dosing decisions, and tailor treatment parameters to individual skin response patterns. In the dermatology excimer laser market, this improves confidence in delivering personalized care, particularly when outcomes depend on accurate targeting and careful adjustment over multiple sessions. The practical effect is stronger adoption among providers seeking more consistent protocols, better workflow efficiency, and technology differentiation, as intelligent planning capabilities make excimer platforms more attractive in dermatology settings where precision and reproducibility directly shape treatment choices.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising prevalence of psoriasis and vitiligo driving demand for targeted laser dermatology treatments | 2.00% | High | North America, Europe | High | Near Term |
| Growing preference for non-invasive cosmetic and dermatology procedures accelerating laser adoption | 1.80% | Moderate | North America, Asia Pacific | High | Near Term |
| Integration of AI-enabled treatment planning improving precision and personalized dermatology care | 1.50% | High | Europe, North America | Emerging | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America held the leading regional position in 2025, accounting for a 40.49% share of the dermatology excimer laser market. This leadership is bolstered by the region’s established dermatology care infrastructure, broad availability of specialist clinics, and routine use of device-based treatment pathways for chronic skin conditions such as psoriasis and vitiligo. In practice, a dense concentration of dermatologists and outpatient aesthetic and medical dermatology centers supports steady procedure volumes, while provider familiarity with excimer laser protocols reinforces repeat adoption in clinical settings.
Asia Pacific is projected to expand at an 11.42% CAGR over the forecast period in the dermatology excimer laser market, driven by rising access to dermatology services and increasing uptake of advanced laser-based treatment across urban healthcare networks. Growth is being fueled by the practical shift toward minimally invasive skin therapy in expanding hospital and specialty clinic environments, where improving device availability and growing patient awareness are translating into higher treatment adoption. As more providers incorporate laser platforms into routine dermatology practice, regional demand is accelerating through a broader base of treatable patients and increasing procedural use.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Specialist Clinic UtilizationGermany is emphasizing dermatology excimer laser technologies within specialized clinics focused on chronic skin disease management. The market in Germany is seeing steady adoption of laser systems that offer localized treatment while minimizing exposure to surrounding healthy tissue.
France 🇫🇷
Chronic Disease Management ToolsFrance is utilizing dermatology excimer lasers as part of comprehensive treatment strategies for persistent skin disorders. The French market is prioritizing technologies that provide targeted intervention options and support individualized patient treatment pathways.
Italy 🇮🇹
Outpatient Treatment EfficiencyItaly is adopting dermatology excimer laser systems that enable efficient outpatient management of psoriasis and vitiligo. Dermatology centers in Italy are focusing on equipment that improves treatment precision and expands noninvasive therapeutic options for patients.
Japan 🇯🇵
Precision Skin TherapiesJapan is increasingly adopting dermatology excimer lasers for targeted treatment approaches that address complex skin conditions. Healthcare providers in Japan value technologies that provide effective therapy with reduced treatment areas and improved patient comfort.
South Korea 🇰🇷
Aesthetic Dermatology ExpansionSouth Korea's strong dermatology sector is supporting broader adoption of excimer laser systems for therapeutic and specialized skin applications. Clinics in South Korea are investing in advanced laser technologies that complement the country's sophisticated dermatological care infrastructure.
United States 🇺🇸
Advanced Dermatology ProceduresThe U.S. dermatology excimer laser market is driven by strong demand for targeted treatments of psoriasis, vitiligo, and other chronic skin disorders. Dermatology clinics in the U.S. are investing in advanced laser platforms that improve treatment precision and patient outcomes.
Segment Leadership and Growth Trends
Dermatology Excimer Laser Market Share (%), Product, 2025
Go beyond the chart, access full insights & data tables
Request Free Sample ReportTrolley Mounted Excimer Lasers held a 46.22% share of the dermatology excimer laser market in 2025, reflecting their established role in clinical settings that handle steady patient volumes and require consistent treatment delivery. Their leadership is underpinned by their suitability for structured dermatology workflows, where larger systems are often preferred for routine use, operator familiarity, and integration into dedicated treatment rooms. In the dermatology excimer laser market, this segment benefits from the practical purchasing behavior of providers that prioritize durable installed equipment for repeat procedures and reliable throughput.
Hand-held Excimer Lasers are emerging as the fastest-growing product segment in the dermatology excimer laser market as providers increasingly value flexibility in treatment delivery and space-efficient equipment deployment. Their growth is being reinforced through the need for more adaptable devices that can fit smaller practice environments and enable targeted use without the infrastructure requirements associated with larger systems. Compared with trolley mounted alternatives, hand-held excimer lasers are gaining momentum because they align more closely with expanding outpatient use patterns and the preference for more portable treatment options.
End-use Segment Analysis: Dermatology Clinics (Largest Segment) vs Plastic Surgery Centers (Fastest-Growing Segment)
By 2025, Dermatology Clinics accounted for the largest share of the dermatology excimer laser market, reinforced through their direct alignment with the diagnosis and routine management of skin conditions commonly treated with excimer laser systems. Their dominant position is sustained by regular patient inflow, specialized clinical expertise, and the fact that these facilities are the most natural point of care for laser-based dermatologic treatment. In the dermatology excimer laser market, demand remains concentrated in dermatology clinics because treatment adoption is closely tied to specialist-led care pathways and recurring procedural use.
Plastic Surgery Centers represent the fastest-growing end-use segment in the dermatology excimer laser market as these centers broaden their procedural mix and incorporate more device-based skin treatment options. Growth is being driven by the practical expansion of service offerings beyond traditional cosmetic procedures, creating space for excimer laser adoption in settings that already invest in advanced dermatologic and aesthetic equipment. Relative to other end-use environments, plastic surgery centers are gaining traction because they can integrate these systems into existing technology-oriented treatment models and patient service structures.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Product | Table Top Excimer Lasers, Hand-held Excimer Lasers, Trolley Mounted Excimer Lasers | Trolley Mounted Excimer Lasers | Hand-held Excimer Lasers |
| End-use | Hospitals, Dermatology Clinics, Plastic Surgery Centers | Dermatology Clinics | Plastic Surgery Centers |
| Application | Psoriasis, Vitiligo, Atopic Dermatitis, Allergic Rhinitis, Alopecia Areata, Others | Psoriasis | Vitiligo |
Competitive Landscape and Market Positioning
1. Ra Medical Systems Inc. (United States)
2. Lumenis Ltd. (Israel)
3. Hologic Inc. (United States)
4. Fotona d.o.o. (Slovenia)
5. Alma Lasers (Israel)
6. Strata Skin Sciences Inc. (United States)
7. DEKA Research & Development Corp. (Italy)
8. Beijing Sincoheren S&T Development Co. Ltd (China)
9. Shenzhen GSD Tech Co. Ltd. (China)
10. The Daavlin Company (United States)
The dermatology excimer laser market is experiencing strong innovation focused on precision-based skin treatment solutions. In the dermatology excimer laser market, technological upgrades are improving treatment accuracy and reducing recovery time. New laser systems are being introduced with enhanced safety and performance features. Continuous research is enabling more effective management of chronic dermatological conditions.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| No companies available. | |||||||
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| STRATA Skin Sciences Inc. | Jul-24 | STRATA Skin Sciences received regulatory approval from Japan’s Ministry of Health, Labour and Welfare for its XTRAC Momentum 1.0 excimer laser device. The approval enables commercialization in Japan through its partner JMEC Co. Ltd., strengthening STRATA’s regional presence and expanding access to excimer laser-based treatments for dermatological conditions including psoriasis and vitiligo. |
| STRATA Skin Sciences, Inc. | Aug-21 | STRATA Skin Sciences acquired the U.S. dermatology division of Ra Medical Systems, including the PHAROS excimer laser system. The acquisition expands STRATA’s excimer laser therapy portfolio and strengthens its position in dermatology treatment systems by integrating additional laser-based therapeutic capabilities. |
| LASEROPTEK Co. Ltd. | Aug-20 | LASEROPTEK launched its PALLAS Solid-State 311nm UVB laser in the U.S., cleared by the FDA for treatment of vitiligo, psoriasis, atopic dermatitis, and leukoderma. The solid-state design eliminates gas and electrodes, improving operational efficiency and strengthening LASEROPTEK’s competitive position in dermatology laser systems. |
| STRATA Skin Sciences, Inc. | Jul-24 | STRATA Skin Sciences expanded commercialization of targeted phototherapy systems for psoriasis treatment programs, supporting broader clinical adoption of its dermatology laser technologies. The initiative reinforces the company’s positioning in excimer-based dermatology treatments and enhances its installed base across clinical settings. |
| Alma Lasers | 2025 | Alma Lasers introduced AI-assisted dermatology laser technologies, enhancing precision and treatment optimization in dermatological procedures. The development strengthens its portfolio in advanced laser-based skin treatment systems and supports broader integration of intelligent technologies in dermatology care workflows. |
| Lumenis, Ltd. | 2023 | Lumenis increased investment in compact dermatology excimer laser systems, focusing on portable and space-efficient treatment solutions. This strategic emphasis supports broader adoption in clinical dermatology settings and strengthens its competitive positioning in minimally invasive laser therapy systems. |
| Fotona d.o.o. | 2024 | Fotona launched enhanced precision phototherapy platforms for vitiligo treatment, expanding its dermatology laser technology offerings. The development reinforces its focus on precision-based skin therapy solutions and strengthens its position in excimer and phototherapy-based dermatology treatment systems. |
| Ra Medical Systems, Inc. | 2025 | Ra Medical Systems expanded research into portable excimer laser technologies for outpatient dermatology clinics, focusing on improving accessibility and mobility of laser-based skin treatments. The initiative supports development of compact systems tailored for decentralized dermatology care settings. |
Explore This Report
Click a section of the wheel — or its numbered marker — to preview the custom segmentation, custom table of contents, or related reports available for this market.
Dermatology Excimer Laser Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| No segment data available. | |
Dermatology Excimer Laser Market — report.custom
| Custom Chapter | Custom Details | ||
|---|---|---|---|
| No custom TOC data available. | |||
Need a different cut of the data?
Request Custom ResearchHow large is the dermatology excimer laser market?
How is the dermatology excimer laser industry projected to perform over the next decade?
How are changing patient preferences influencing adoption of excimer laser treatments?
How is AI-enabled treatment planning shaping the future of dermatology laser adoption?
Which end-use segment holds the largest share of the dermatology excimer laser market?
Why are hand-held excimer lasers the fastest-growing product segment?
Why is North America the leading regional market for dermatology excimer lasers?
What is fueling the growth of the dermatology excimer laser market in Asia Pacific?
Who holds a significant market share in the dermatology excimer laser landscape?
Our Clients
"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."
"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."
"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source Category | Research Sources | Purpose |
|---|---|---|
| Government Publications | Government agencies, statistical departments, regulatory bodies | Industry statistics, regulatory insights, and policy analysis |
| Company Disclosures | Annual reports, investor presentations, financial filings | Company performance, business strategy, and market positioning |
| Trade Associations | Industry associations and professional organizations | Industry developments, standards, and market perspectives |
| Technical Literature | Research papers, technical publications, academic journals | Technology developments and technical validation |
| Patent Analysis | Patent databases and intellectual property publications | Innovation trends, technology activity, and competitive research |
| Industry Databases | Established research databases and market intelligence resources | Market benchmarking, historical data, and industry analysis |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization